Compugen Ltd. (CGEN) vs MacroGenics, Inc. (MGNX)

A side-by-side comparison of Compugen Ltd. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGEN vs MGNX

growth of $100 · dividends reinvested · last 10y
CGEN -63.7% (-9.6%/yr)MGNX -87.5% (-18.7%/yr)CGEN compounded faster over this window
0100200300Start $10020182020202220242026$36$13
CGEN MGNX

CGEN vs MGNX: by the numbers

  • •MGNX is the larger company ($235M vs $214M market cap).
  • •CGEN is profitable (47.55% net margin) while MGNX runs a net loss (-8.70%).
  • •CGEN grew revenue faster over the past five years (105.91% vs 7.33% CAGR).

Metrics side by side

Valuation

MetricCGENMGNX
P/E ratio6.03N/A
P/S ratio2.891.40
P/B ratio2.415.49

Profitability

MetricCGENMGNX
Gross margin86.89%71.12%
Operating margin40.94%-48.72%
Net margin47.55%-8.70%
ROE39.66%-34.04%
ROIC26.14%-16.87%

Growth (annualized)

MetricCGENMGNX
Revenue CAGR (5Y)105.91%7.33%
Total return CAGR (5Y)-18.39%-28.42%

Frequently asked

Which has grown faster, CGEN or MGNX?
Over the past five years, CGEN grew revenue faster — CGEN at a 105.91% CAGR versus MGNX at 7.33%.
Is CGEN or MGNX more profitable?
CGEN runs the higher net margin — CGEN at 47.55% versus MGNX at -8.70%.
How have CGEN and MGNX total returns compared?
Over the past 10 years, CGEN delivered -9.42% and MGNX delivered -18.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.